

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.50167401 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.50167401 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.20288872 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.20288872 |
| 5 | embryonic process involved in female pregnancy (GO:0060136) | 5.15142417 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 4.93853407 |
| 7 | cysteine metabolic process (GO:0006534) | 4.81245302 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.70846853 |
| 9 | kynurenine metabolic process (GO:0070189) | 4.51474535 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.42209292 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.42209292 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.42209292 |
| 13 | glyoxylate metabolic process (GO:0046487) | 4.36558503 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.25267733 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.21277320 |
| 16 | complement activation, alternative pathway (GO:0006957) | 4.20255245 |
| 17 | urea cycle (GO:0000050) | 4.19981688 |
| 18 | urea metabolic process (GO:0019627) | 4.19981688 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.17827520 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 4.15699462 |
| 21 | hemidesmosome assembly (GO:0031581) | 4.12692348 |
| 22 | protein carboxylation (GO:0018214) | 4.12132856 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.12132856 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.08002239 |
| 25 | lysine catabolic process (GO:0006554) | 4.07836571 |
| 26 | lysine metabolic process (GO:0006553) | 4.07836571 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.07562736 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.06878745 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 4.05347282 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 3.97999168 |
| 31 | iron ion import (GO:0097286) | 3.87443194 |
| 32 | regulation of complement activation (GO:0030449) | 3.86175377 |
| 33 | homocysteine metabolic process (GO:0050667) | 3.85366197 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 3.82206401 |
| 35 | glutamate metabolic process (GO:0006536) | 3.81196406 |
| 36 | bile acid metabolic process (GO:0008206) | 3.77614723 |
| 37 | plasma lipoprotein particle clearance (GO:0034381) | 3.76117210 |
| 38 | phospholipid efflux (GO:0033700) | 3.75304868 |
| 39 | reverse cholesterol transport (GO:0043691) | 3.74658256 |
| 40 | bile acid and bile salt transport (GO:0015721) | 3.74359140 |
| 41 | negative regulation of sterol transport (GO:0032372) | 3.68265145 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 3.68265145 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.63354523 |
| 44 | cell adhesion mediated by integrin (GO:0033627) | 3.60290642 |
| 45 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.59053260 |
| 46 | drug catabolic process (GO:0042737) | 3.58776289 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 3.58416199 |
| 48 | triglyceride homeostasis (GO:0070328) | 3.58176403 |
| 49 | acylglycerol homeostasis (GO:0055090) | 3.58176403 |
| 50 | tyrosine metabolic process (GO:0006570) | 3.57416308 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 3.55222947 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 3.53476605 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 3.52787179 |
| 54 | glycosphingolipid catabolic process (GO:0046479) | 3.52115382 |
| 55 | drug transmembrane transport (GO:0006855) | 3.47839307 |
| 56 | cholesterol efflux (GO:0033344) | 3.47481991 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 3.45254115 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.45254115 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.45254115 |
| 60 | desmosome organization (GO:0002934) | 3.44980812 |
| 61 | alpha-amino acid catabolic process (GO:1901606) | 3.41390884 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 3.40891539 |
| 63 | regulation of bile acid biosynthetic process (GO:0070857) | 3.38954276 |
| 64 | urate metabolic process (GO:0046415) | 3.32146045 |
| 65 | plasma lipoprotein particle assembly (GO:0034377) | 3.31228646 |
| 66 | fibrinolysis (GO:0042730) | 3.30980130 |
| 67 | phospholipid homeostasis (GO:0055091) | 3.30408175 |
| 68 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.29413044 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 3.28910971 |
| 70 | cellular glucuronidation (GO:0052695) | 3.27756508 |
| 71 | regulation of cholesterol esterification (GO:0010872) | 3.26440371 |
| 72 | heme transport (GO:0015886) | 3.26181478 |
| 73 | glycolipid catabolic process (GO:0019377) | 3.22783879 |
| 74 | oligosaccharide catabolic process (GO:0009313) | 3.21323907 |
| 75 | response to laminar fluid shear stress (GO:0034616) | 3.20313008 |
| 76 | sterol homeostasis (GO:0055092) | 3.19386032 |
| 77 | cholesterol homeostasis (GO:0042632) | 3.18941540 |
| 78 | exogenous drug catabolic process (GO:0042738) | 3.17414714 |
| 79 | protein-lipid complex assembly (GO:0065005) | 3.17087298 |
| 80 | cellular amino acid catabolic process (GO:0009063) | 3.16216021 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 3.12455499 |
| 82 | indolalkylamine metabolic process (GO:0006586) | 3.09303828 |
| 83 | arginine metabolic process (GO:0006525) | 3.09062963 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 3.08788594 |
| 85 | serine family amino acid metabolic process (GO:0009069) | 3.08356238 |
| 86 | short-chain fatty acid metabolic process (GO:0046459) | 3.07528007 |
| 87 | acetyl-CoA metabolic process (GO:0006084) | 3.02650531 |
| 88 | ketone body metabolic process (GO:1902224) | 3.02335846 |
| 89 | ethanol oxidation (GO:0006069) | 3.01149322 |
| 90 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97905610 |
| 91 | uronic acid metabolic process (GO:0006063) | 2.95928815 |
| 92 | glucuronate metabolic process (GO:0019585) | 2.95928815 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 2.94967478 |
| 94 | lipoprotein metabolic process (GO:0042157) | 2.91366138 |
| 95 | cellular biogenic amine catabolic process (GO:0042402) | 2.90639218 |
| 96 | amine catabolic process (GO:0009310) | 2.90639218 |
| 97 | wound healing, spreading of epidermal cells (GO:0035313) | 2.89305991 |
| 98 | nuclear pore complex assembly (GO:0051292) | 2.88981761 |
| 99 | low-density lipoprotein particle clearance (GO:0034383) | 2.88676832 |
| 100 | lipid homeostasis (GO:0055088) | 2.88055992 |
| 101 | response to nitrosative stress (GO:0051409) | 2.87473195 |
| 102 | coenzyme catabolic process (GO:0009109) | 2.87446343 |
| 103 | flavonoid metabolic process (GO:0009812) | 2.87000773 |
| 104 | intestinal cholesterol absorption (GO:0030299) | 2.86807114 |
| 105 | apoptotic cell clearance (GO:0043277) | 2.83649277 |
| 106 | response to mercury ion (GO:0046689) | 2.82015594 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 2.80978922 |
| 108 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.80464069 |
| 109 | glycine metabolic process (GO:0006544) | 2.79919144 |
| 110 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.78410504 |
| 111 | negative regulation of lipase activity (GO:0060192) | 2.77798149 |
| 112 | cellular protein complex localization (GO:0034629) | 2.77651921 |
| 113 | protein localization to endosome (GO:0036010) | 2.76606763 |
| 114 | cell-substrate junction assembly (GO:0007044) | 2.76074270 |
| 115 | protein-lipid complex subunit organization (GO:0071825) | 2.76009734 |
| 116 | fatty acid oxidation (GO:0019395) | 2.75599987 |
| 117 | negative regulation of fatty acid transport (GO:2000192) | 2.75031158 |
| 118 | midgut development (GO:0007494) | 2.74635074 |
| 119 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.73675943 |
| 120 | skin morphogenesis (GO:0043589) | 2.63992636 |
| 121 | positive regulation of extracellular matrix organization (GO:1903055) | 2.63477350 |
| 122 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.62987976 |
| 123 | nuclear pore organization (GO:0006999) | 2.61671602 |
| 124 | endodermal cell differentiation (GO:0035987) | 2.61060650 |
| 125 | gap junction assembly (GO:0016264) | 2.58793535 |
| 126 | ceramide catabolic process (GO:0046514) | 2.57643825 |
| 127 | regulation of early endosome to late endosome transport (GO:2000641) | 2.57242318 |
| 128 | COPII vesicle coating (GO:0048208) | 2.56198472 |
| 129 | positive regulation of p38MAPK cascade (GO:1900745) | 2.53438962 |
| 130 | cellular response to arsenic-containing substance (GO:0071243) | 2.51694821 |
| 131 | wound healing, spreading of cells (GO:0044319) | 2.51445647 |
| 132 | positive regulation of cholesterol efflux (GO:0010875) | 2.49672165 |
| 133 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.47816942 |
| 134 | positive regulation of sterol transport (GO:0032373) | 2.46658178 |
| 135 | positive regulation of cholesterol transport (GO:0032376) | 2.46658178 |
| 136 | regulation of vitamin metabolic process (GO:0030656) | 2.45876889 |
| 137 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.45124078 |
| 138 | intestinal absorption (GO:0050892) | 2.44793925 |
| 139 | epoxygenase P450 pathway (GO:0019373) | 2.44091046 |
| 140 | angiotensin maturation (GO:0002003) | 2.42793707 |
| 141 | response to thyroid hormone (GO:0097066) | 2.41912032 |
| 142 | pinocytosis (GO:0006907) | 2.41355777 |
| 143 | detection of molecule of bacterial origin (GO:0032490) | 2.40170373 |
| 144 | mammary gland epithelial cell proliferation (GO:0033598) | 2.38626539 |
| 145 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.38619610 |
| 146 | omega-hydroxylase P450 pathway (GO:0097267) | 2.37639950 |
| 147 | hyaluronan catabolic process (GO:0030214) | 2.36713710 |
| 148 | decidualization (GO:0046697) | 2.34895817 |
| 149 | epithelial cell-cell adhesion (GO:0090136) | 2.34411924 |
| 150 | regulation of macrophage chemotaxis (GO:0010758) | 2.33866721 |
| 151 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.32961358 |
| 152 | negative regulation of lipid transport (GO:0032369) | 2.32872436 |
| 153 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.32359653 |
| 154 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.31317698 |
| 155 | surfactant homeostasis (GO:0043129) | 2.31188247 |
| 156 | Rap protein signal transduction (GO:0032486) | 2.30513713 |
| 157 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.30438031 |
| 158 | positive regulation of osteoblast proliferation (GO:0033690) | 2.28846420 |
| 159 | negative regulation of protein activation cascade (GO:2000258) | 2.28413394 |
| 160 | basement membrane organization (GO:0071711) | 2.27788572 |
| 161 | cellular response to ethanol (GO:0071361) | 2.27681606 |
| 162 | pore complex assembly (GO:0046931) | 2.26571661 |
| 163 | positive regulation of blood coagulation (GO:0030194) | 2.26529863 |
| 164 | positive regulation of hemostasis (GO:1900048) | 2.26529863 |
| 165 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.26447423 |
| 166 | hepatocyte differentiation (GO:0070365) | 2.25491384 |
| 167 | negative regulation of complement activation (GO:0045916) | 2.24370500 |
| 168 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.23253373 |
| 169 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.23145419 |
| 170 | positive regulation of coagulation (GO:0050820) | 2.22103543 |
| 171 | response to arsenic-containing substance (GO:0046685) | 2.20478691 |
| 172 | osteoclast differentiation (GO:0030316) | 2.20242232 |
| 173 | negative regulation of anoikis (GO:2000811) | 2.20025948 |
| 174 | regulation of apoptotic cell clearance (GO:2000425) | 2.19948914 |
| 175 | regulation of cholesterol storage (GO:0010885) | 2.19906375 |
| 176 | stress fiber assembly (GO:0043149) | 2.19442945 |
| 177 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.18395677 |
| 178 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.18012779 |
| 179 | sphingosine metabolic process (GO:0006670) | 2.16412375 |
| 180 | ER overload response (GO:0006983) | 2.16269452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.91678189 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.09127550 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.38324584 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.29940994 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.41047817 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.25342130 |
| 7 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.89036019 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.71515909 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.71175468 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34941875 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28644644 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24209129 |
| 13 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.18712482 |
| 14 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.18712482 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07555547 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02341049 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01851402 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.96843003 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81420940 |
| 20 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.78995549 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.78941664 |
| 22 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.75810993 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.75763463 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.69974715 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66203098 |
| 26 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.63141598 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61379506 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.58845366 |
| 29 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57508113 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57426260 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57391228 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54412855 |
| 33 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.48642051 |
| 34 | GATA1_19941826_ChIP-Seq_K562_Human | 1.48144558 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45719491 |
| 36 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.45185643 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.43441389 |
| 38 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.43012248 |
| 39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40985432 |
| 40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40010075 |
| 41 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.38615264 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37069691 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.36856595 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36644898 |
| 45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35817052 |
| 46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.34200952 |
| 47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.33506880 |
| 48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29713799 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29644612 |
| 50 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28564751 |
| 51 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24222266 |
| 52 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23826707 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22989480 |
| 54 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.22320179 |
| 55 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21896499 |
| 56 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21896499 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21303235 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21068855 |
| 59 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16741583 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16620373 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15565225 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14644810 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11803981 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09514409 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07263132 |
| 66 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06877784 |
| 67 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.06255592 |
| 68 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05446058 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04859559 |
| 70 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.04514026 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03950911 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03490946 |
| 73 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01968175 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01341618 |
| 75 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01259239 |
| 76 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00321850 |
| 77 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00237903 |
| 78 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00038835 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99638743 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98923082 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98448012 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97946372 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96636992 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95568219 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95318251 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95202064 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94947628 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94579492 |
| 89 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.93796329 |
| 90 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93593357 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92850443 |
| 92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.92186641 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.92089754 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90816093 |
| 95 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90769286 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87632434 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87513883 |
| 98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87425016 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86682051 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86107984 |
| 101 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.85073479 |
| 102 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.84255275 |
| 103 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84082362 |
| 104 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82814692 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81765505 |
| 106 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.80114013 |
| 107 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79967290 |
| 108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79961107 |
| 109 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.79737745 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.79626898 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79617664 |
| 112 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79135269 |
| 113 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78322896 |
| 114 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78288280 |
| 115 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78054250 |
| 116 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.77202347 |
| 117 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77191529 |
| 118 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77006040 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75914325 |
| 120 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.75792443 |
| 121 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.75417082 |
| 122 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75191661 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 0.73557020 |
| 124 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72706588 |
| 125 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.72612754 |
| 126 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.71607633 |
| 127 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.71607633 |
| 128 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71570179 |
| 129 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.70985778 |
| 130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70676311 |
| 131 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.70497121 |
| 132 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.69362731 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.68583266 |
| 134 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68567913 |
| 135 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.68305759 |
| 136 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67869304 |
| 137 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.67494692 |
| 138 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.67256001 |
| 139 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67253797 |
| 140 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.66453026 |
| 141 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.65810054 |
| 142 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65471629 |
| 143 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65190554 |
| 144 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.64869286 |
| 145 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64804493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.38081854 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.17343255 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.89606311 |
| 4 | MP0005365_abnormal_bile_salt | 4.48591651 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.27887806 |
| 6 | MP0003252_abnormal_bile_duct | 3.05040774 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 3.04881738 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.87952974 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.85465113 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.60030314 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 2.59224756 |
| 12 | MP0009840_abnormal_foam_cell | 2.47404861 |
| 13 | MP0005332_abnormal_amino_acid | 2.32749452 |
| 14 | MP0002796_impaired_skin_barrier | 2.29525112 |
| 15 | MP0005083_abnormal_biliary_tract | 2.28857841 |
| 16 | MP0008438_abnormal_cutaneous_collagen | 2.27707781 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.24067517 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.21629849 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.10504806 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.06792090 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 2.01393306 |
| 22 | MP0010678_abnormal_skin_adnexa | 1.99109925 |
| 23 | MP0003195_calcinosis | 1.98700788 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.97980424 |
| 25 | MP0003828_pulmonary_edema | 1.88313496 |
| 26 | MP0003091_abnormal_cell_migration | 1.87807195 |
| 27 | MP0002254_reproductive_system_inflammat | 1.82859458 |
| 28 | MP0000579_abnormal_nail_morphology | 1.82241541 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.78042205 |
| 30 | MP0000609_abnormal_liver_physiology | 1.76749577 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.74187918 |
| 32 | MP0002822_catalepsy | 1.72525618 |
| 33 | MP0001661_extended_life_span | 1.72462229 |
| 34 | MP0000383_abnormal_hair_follicle | 1.65674259 |
| 35 | MP0005409_darkened_coat_color | 1.64976454 |
| 36 | MP0002098_abnormal_vibrissa_morphology | 1.61643586 |
| 37 | MP0000537_abnormal_urethra_morphology | 1.59901977 |
| 38 | MP0002009_preneoplasia | 1.56261410 |
| 39 | MP0010307_abnormal_tumor_latency | 1.49651703 |
| 40 | MP0005023_abnormal_wound_healing | 1.49305460 |
| 41 | MP0000647_abnormal_sebaceous_gland | 1.48769778 |
| 42 | MP0003690_abnormal_glial_cell | 1.42938796 |
| 43 | MP0010368_abnormal_lymphatic_system | 1.42035036 |
| 44 | MP0001849_ear_inflammation | 1.36541882 |
| 45 | MP0000858_altered_metastatic_potential | 1.34871826 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.32810053 |
| 47 | MP0003868_abnormal_feces_composition | 1.31668635 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.31388722 |
| 49 | MP0008260_abnormal_autophagy | 1.29881288 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.29820723 |
| 51 | MP0009053_abnormal_anal_canal | 1.28228687 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.27963169 |
| 53 | MP0005451_abnormal_body_composition | 1.24533487 |
| 54 | MP0005501_abnormal_skin_physiology | 1.24413618 |
| 55 | MP0003448_altered_tumor_morphology | 1.23293788 |
| 56 | MP0000377_abnormal_hair_follicle | 1.18473191 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17856265 |
| 58 | MP0006082_CNS_inflammation | 1.15835025 |
| 59 | MP0001915_intracranial_hemorrhage | 1.15333758 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.15166461 |
| 61 | MP0000427_abnormal_hair_cycle | 1.13147293 |
| 62 | MP0000604_amyloidosis | 1.11768517 |
| 63 | MP0005257_abnormal_intraocular_pressure | 1.11027407 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.10192685 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.08408738 |
| 66 | MP0004885_abnormal_endolymph | 1.08338034 |
| 67 | MP0004043_abnormal_pH_regulation | 1.07349758 |
| 68 | MP0000343_altered_response_to | 1.06878050 |
| 69 | MP0005164_abnormal_response_to | 1.06421979 |
| 70 | MP0005670_abnormal_white_adipose | 1.06312889 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.01439418 |
| 72 | MP0004130_abnormal_muscle_cell | 1.01182640 |
| 73 | MP0003436_decreased_susceptibility_to | 1.00053807 |
| 74 | MP0002166_altered_tumor_susceptibility | 0.97361772 |
| 75 | MP0001851_eye_inflammation | 0.97209984 |
| 76 | MP0001191_abnormal_skin_condition | 0.97139821 |
| 77 | MP0008057_abnormal_DNA_replication | 0.97110381 |
| 78 | MP0004272_abnormal_basement_membrane | 0.92901732 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.92021974 |
| 80 | MP0006054_spinal_hemorrhage | 0.91611041 |
| 81 | MP0004947_skin_inflammation | 0.89646517 |
| 82 | MP0002419_abnormal_innate_immunity | 0.89211379 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 0.88568334 |
| 84 | MP0005666_abnormal_adipose_tissue | 0.87548882 |
| 85 | MP0002971_abnormal_brown_adipose | 0.86968534 |
| 86 | MP0003329_amyloid_beta_deposits | 0.86922839 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.85694573 |
| 88 | MP0005275_abnormal_skin_tensile | 0.85642762 |
| 89 | MP0000598_abnormal_liver_morphology | 0.84624809 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.83048574 |
| 91 | MP0004233_abnormal_muscle_weight | 0.82223665 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.81970620 |
| 93 | MP0003279_aneurysm | 0.81514481 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.81238663 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.80222129 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.80190557 |
| 97 | MP0009384_cardiac_valve_regurgitation | 0.79943038 |
| 98 | MP0001756_abnormal_urination | 0.79424445 |
| 99 | MP0002086_abnormal_extraembryonic_tissu | 0.79241064 |
| 100 | MP0003941_abnormal_skin_development | 0.79165751 |
| 101 | MP0001533_abnormal_skeleton_physiology | 0.77471808 |
| 102 | MP0002006_tumorigenesis | 0.75492096 |
| 103 | MP0009764_decreased_sensitivity_to | 0.75326020 |
| 104 | MP0009785_altered_susceptibility_to | 0.75274671 |
| 105 | MP0005397_hematopoietic_system_phenotyp | 0.75120114 |
| 106 | MP0001545_abnormal_hematopoietic_system | 0.75120114 |
| 107 | MP0003075_altered_response_to | 0.75110371 |
| 108 | MP0005621_abnormal_cell_physiology | 0.73947622 |
| 109 | MP0001853_heart_inflammation | 0.73323377 |
| 110 | MP0005084_abnormal_gallbladder_morpholo | 0.73304462 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.72028796 |
| 112 | MP0005197_abnormal_uvea_morphology | 0.71203319 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.70956820 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.70799067 |
| 115 | MP0009763_increased_sensitivity_to | 0.70665817 |
| 116 | MP0000627_abnormal_mammary_gland | 0.70240348 |
| 117 | MP0004808_abnormal_hematopoietic_stem | 0.69561461 |
| 118 | MP0000920_abnormal_myelination | 0.69398521 |
| 119 | MP0002148_abnormal_hypersensitivity_rea | 0.68621355 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.67358572 |
| 121 | MP0002090_abnormal_vision | 0.66927973 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.66597468 |
| 123 | MP0010771_integument_phenotype | 0.66549388 |
| 124 | MP0005647_abnormal_sex_gland | 0.66170389 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.65526856 |
| 126 | MP0005623_abnormal_meninges_morphology | 0.64105716 |
| 127 | MP0005535_abnormal_body_temperature | 0.62544735 |
| 128 | MP0003633_abnormal_nervous_system | 0.62319307 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.61542965 |
| 130 | MP0003303_peritoneal_inflammation | 0.61440555 |
| 131 | MP0001879_abnormal_lymphatic_vessel | 0.61237779 |
| 132 | MP0004147_increased_porphyrin_level | 0.60544618 |
| 133 | MP0005166_decreased_susceptibility_to | 0.60504017 |
| 134 | MP0003011_delayed_dark_adaptation | 0.60074537 |
| 135 | MP0005334_abnormal_fat_pad | 0.57989190 |
| 136 | MP0003186_abnormal_redox_activity | 0.56849012 |
| 137 | MP0002078_abnormal_glucose_homeostasis | 0.55859252 |
| 138 | MP0002060_abnormal_skin_morphology | 0.55577945 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.55221564 |
| 140 | MP0001765_abnormal_ion_homeostasis | 0.54936177 |
| 141 | MP0005187_abnormal_penis_morphology | 0.54841591 |
| 142 | MP0009931_abnormal_skin_appearance | 0.54029049 |
| 143 | MP0009642_abnormal_blood_homeostasis | 0.53938796 |
| 144 | MP0005408_hypopigmentation | 0.51433815 |
| 145 | MP0002896_abnormal_bone_mineralization | 0.51261165 |
| 146 | MP0005375_adipose_tissue_phenotype | 0.50840671 |
| 147 | MP0008874_decreased_physiological_sensi | 0.50321224 |
| 148 | MP0005330_cardiomyopathy | 0.50097104 |
| 149 | MP0005165_increased_susceptibility_to | 0.49537962 |
| 150 | MP0009697_abnormal_copulation | 0.49367442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.89348961 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.63411589 |
| 3 | Xanthomatosis (HP:0000991) | 5.44496858 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.77439200 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.76119241 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.71198656 |
| 7 | Complement deficiency (HP:0004431) | 4.52429884 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.13685661 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.11949116 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78073322 |
| 11 | Hypoalphalipoproteinemia (HP:0003233) | 3.71407484 |
| 12 | Hypolipoproteinemia (HP:0010981) | 3.66006722 |
| 13 | Epidermoid cyst (HP:0200040) | 3.61581275 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.60266529 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.58169337 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.58169337 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.58169337 |
| 18 | Abnormality of complement system (HP:0005339) | 3.31610644 |
| 19 | Hyperammonemia (HP:0001987) | 3.31063323 |
| 20 | Hyperglycinemia (HP:0002154) | 3.28021397 |
| 21 | Fat malabsorption (HP:0002630) | 3.24836205 |
| 22 | Hypercholesterolemia (HP:0003124) | 3.24325854 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.18982225 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.17489421 |
| 25 | Ketosis (HP:0001946) | 3.13895724 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 3.12033940 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.12033940 |
| 28 | Joint hemorrhage (HP:0005261) | 3.10845610 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.10664357 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.05150067 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.02071291 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.02071291 |
| 33 | Malnutrition (HP:0004395) | 3.00998706 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.94171007 |
| 35 | Esophageal varix (HP:0002040) | 2.92650383 |
| 36 | Polycythemia (HP:0001901) | 2.91650613 |
| 37 | Hyperglycinuria (HP:0003108) | 2.91019866 |
| 38 | Myocardial infarction (HP:0001658) | 2.80733542 |
| 39 | Gout (HP:0001997) | 2.77121194 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 2.74495468 |
| 41 | Vertebral compression fractures (HP:0002953) | 2.71069995 |
| 42 | Acanthocytosis (HP:0001927) | 2.62078214 |
| 43 | Atrophic scars (HP:0001075) | 2.57460292 |
| 44 | Delayed CNS myelination (HP:0002188) | 2.57282324 |
| 45 | Onycholysis (HP:0001806) | 2.54974465 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.54700312 |
| 47 | Status epilepticus (HP:0002133) | 2.53755010 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.53644230 |
| 49 | Premature rupture of membranes (HP:0001788) | 2.53429230 |
| 50 | Sensorimotor neuropathy (HP:0007141) | 2.49132264 |
| 51 | Abnormality of nail color (HP:0100643) | 2.48536260 |
| 52 | Abnormality of methionine metabolism (HP:0010901) | 2.47840317 |
| 53 | Hemorrhage of the eye (HP:0011885) | 2.43308290 |
| 54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.40508470 |
| 55 | Right ventricular cardiomyopathy (HP:0011663) | 2.39750612 |
| 56 | Tetraparesis (HP:0002273) | 2.38640568 |
| 57 | Confusion (HP:0001289) | 2.35089618 |
| 58 | Abnormality of nucleobase metabolism (HP:0010932) | 2.34184118 |
| 59 | Flat acetabular roof (HP:0003180) | 2.33857010 |
| 60 | Reticulocytosis (HP:0001923) | 2.33805600 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.33754138 |
| 62 | Cerebral inclusion bodies (HP:0100314) | 2.32612198 |
| 63 | Skin nodule (HP:0200036) | 2.32580227 |
| 64 | Spastic diplegia (HP:0001264) | 2.32405752 |
| 65 | Steatorrhea (HP:0002570) | 2.32011907 |
| 66 | Conjugated hyperbilirubinemia (HP:0002908) | 2.31925593 |
| 67 | Arterial tortuosity (HP:0005116) | 2.31885912 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.30188811 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.30163721 |
| 70 | Ketoacidosis (HP:0001993) | 2.28958287 |
| 71 | Vascular calcification (HP:0004934) | 2.28438232 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.27907208 |
| 73 | Alopecia of scalp (HP:0002293) | 2.27734940 |
| 74 | Milia (HP:0001056) | 2.24930121 |
| 75 | Spontaneous abortion (HP:0005268) | 2.24316753 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.23879107 |
| 77 | Poikilocytosis (HP:0004447) | 2.21394298 |
| 78 | Glomerulonephritis (HP:0000099) | 2.20817434 |
| 79 | Hyperuricemia (HP:0002149) | 2.20512381 |
| 80 | Increased purine levels (HP:0004368) | 2.20512381 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.20276227 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.19224140 |
| 83 | Protrusio acetabuli (HP:0003179) | 2.17967919 |
| 84 | Axonal loss (HP:0003447) | 2.17631781 |
| 85 | Increased CSF protein (HP:0002922) | 2.17126465 |
| 86 | Syringomyelia (HP:0003396) | 2.13739709 |
| 87 | Spinal cord lesions (HP:0100561) | 2.13739709 |
| 88 | Rickets (HP:0002748) | 2.13435242 |
| 89 | Bone pain (HP:0002653) | 2.13180783 |
| 90 | Abnormal cartilage morphology (HP:0002763) | 2.13148318 |
| 91 | Mucopolysacchariduria (HP:0008155) | 2.08625058 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08625058 |
| 93 | Global brain atrophy (HP:0002283) | 2.08622039 |
| 94 | Cardiovascular calcification (HP:0011915) | 2.08087503 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07963849 |
| 96 | Back pain (HP:0003418) | 2.07490696 |
| 97 | Vascular tortuosity (HP:0004948) | 2.06953279 |
| 98 | Plantar hyperkeratosis (HP:0007556) | 2.06718093 |
| 99 | Follicular hyperkeratosis (HP:0007502) | 2.05964532 |
| 100 | Subacute progressive viral hepatitis (HP:0006572) | 2.02633762 |
| 101 | Cerebral aneurysm (HP:0004944) | 2.02495997 |
| 102 | Cholelithiasis (HP:0001081) | 2.02481002 |
| 103 | Abnormality of proline metabolism (HP:0010907) | 2.01689197 |
| 104 | Hydroxyprolinuria (HP:0003080) | 2.01689197 |
| 105 | Abnormal gallbladder morphology (HP:0012437) | 2.00609936 |
| 106 | Ankyloglossia (HP:0010296) | 1.99506585 |
| 107 | Nephritis (HP:0000123) | 1.98940483 |
| 108 | Pathologic fracture (HP:0002756) | 1.98798523 |
| 109 | Hypotrichosis (HP:0001006) | 1.97897676 |
| 110 | Woolly hair (HP:0002224) | 1.97599859 |
| 111 | Asymmetry of the thorax (HP:0001555) | 1.97571510 |
| 112 | Abnormality of the Achilles tendon (HP:0005109) | 1.97467576 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97279530 |
| 114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97279530 |
| 115 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97279530 |
| 116 | Thin bony cortex (HP:0002753) | 1.94912053 |
| 117 | Fragile skin (HP:0001030) | 1.92949821 |
| 118 | Natal tooth (HP:0000695) | 1.92944000 |
| 119 | Abnormality of macrophages (HP:0004311) | 1.91107285 |
| 120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89933432 |
| 121 | Intention tremor (HP:0002080) | 1.89537514 |
| 122 | Hypoglycemic seizures (HP:0002173) | 1.88276948 |
| 123 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87851002 |
| 124 | Periodontitis (HP:0000704) | 1.87512966 |
| 125 | Metabolic acidosis (HP:0001942) | 1.86517886 |
| 126 | Loss of speech (HP:0002371) | 1.84910528 |
| 127 | Disinhibition (HP:0000734) | 1.84346658 |
| 128 | Hypophosphatemic rickets (HP:0004912) | 1.84338006 |
| 129 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83219406 |
| 130 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82269451 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 1.81252964 |
| 132 | Cholecystitis (HP:0001082) | 1.81252964 |
| 133 | Upper motor neuron abnormality (HP:0002127) | 1.81041291 |
| 134 | Pili torti (HP:0003777) | 1.80893183 |
| 135 | Irritability (HP:0000737) | 1.80849947 |
| 136 | Hematochezia (HP:0002573) | 1.80010220 |
| 137 | Protuberant abdomen (HP:0001538) | 1.78310334 |
| 138 | Alkalosis (HP:0001948) | 1.78188341 |
| 139 | Pigmentary retinal degeneration (HP:0001146) | 1.77040232 |
| 140 | Wormian bones (HP:0002645) | 1.76400787 |
| 141 | Advanced eruption of teeth (HP:0006288) | 1.76249567 |
| 142 | Coarse hair (HP:0002208) | 1.75886950 |
| 143 | Abnormality of oral frenula (HP:0000190) | 1.75603756 |
| 144 | Conjunctival telangiectasia (HP:0000524) | 1.75476126 |
| 145 | Neonatal onset (HP:0003623) | 1.75053402 |
| 146 | Short nail (HP:0001799) | 1.73193557 |
| 147 | Amyloidosis (HP:0011034) | 1.72254072 |
| 148 | Thick nail (HP:0001805) | 1.70501698 |
| 149 | Mitral stenosis (HP:0001718) | 1.70351143 |
| 150 | Visceral angiomatosis (HP:0100761) | 1.69962440 |
| 151 | Abnormality of serum amino acid levels (HP:0003112) | 1.69285832 |
| 152 | Focal segmental glomerulosclerosis (HP:0000097) | 1.69281389 |
| 153 | Nuclear cataract (HP:0100018) | 1.68804982 |
| 154 | Curly hair (HP:0002212) | 1.68304688 |
| 155 | Fragile nails (HP:0001808) | 1.68000194 |
| 156 | Abnormality of the lumbar spine (HP:0100712) | 1.67102360 |
| 157 | Abnormality of carpal bone ossification (HP:0006257) | 1.66392856 |
| 158 | Hyperparathyroidism (HP:0000843) | 1.65202134 |
| 159 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.65028092 |
| 160 | Cervical subluxation (HP:0003308) | 1.64073076 |
| 161 | Ridged nail (HP:0001807) | 1.62385616 |
| 162 | Gingivitis (HP:0000230) | 1.60395790 |
| 163 | Spondylolisthesis (HP:0003302) | 1.59231366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 3.70593113 |
| 2 | LATS1 | 2.89056690 |
| 3 | PRPF4B | 2.88244928 |
| 4 | KSR2 | 2.87396209 |
| 5 | BRD4 | 2.82494105 |
| 6 | MAP3K2 | 2.61747942 |
| 7 | BRSK2 | 2.37989140 |
| 8 | IRAK3 | 2.21759149 |
| 9 | EPHA4 | 2.17495090 |
| 10 | STK24 | 1.95300542 |
| 11 | MET | 1.92007673 |
| 12 | ACVR1B | 1.91545880 |
| 13 | TIE1 | 1.87973406 |
| 14 | FGFR4 | 1.76835878 |
| 15 | PIM2 | 1.58598721 |
| 16 | ERBB4 | 1.58320295 |
| 17 | TAOK1 | 1.58116923 |
| 18 | SCYL2 | 1.57652341 |
| 19 | NEK9 | 1.53951996 |
| 20 | WNK4 | 1.53033240 |
| 21 | FGFR2 | 1.51605855 |
| 22 | MAP3K14 | 1.51557022 |
| 23 | AKT3 | 1.48953942 |
| 24 | ERN1 | 1.47006502 |
| 25 | PBK | 1.44528577 |
| 26 | TAOK3 | 1.41547233 |
| 27 | KDR | 1.41230326 |
| 28 | PTK6 | 1.39487597 |
| 29 | WEE1 | 1.38075309 |
| 30 | BMPR2 | 1.35547983 |
| 31 | TRIB3 | 1.34941541 |
| 32 | MAP3K10 | 1.34586680 |
| 33 | PAK4 | 1.34448826 |
| 34 | INSRR | 1.32507037 |
| 35 | SIK1 | 1.31973837 |
| 36 | RET | 1.31480127 |
| 37 | MAP2K4 | 1.31132570 |
| 38 | EPHB1 | 1.30836127 |
| 39 | DDR2 | 1.29112293 |
| 40 | BCKDK | 1.27960052 |
| 41 | PTK2 | 1.26830845 |
| 42 | MAP3K1 | 1.26287884 |
| 43 | DMPK | 1.25655674 |
| 44 | TYK2 | 1.25594443 |
| 45 | STK39 | 1.25134430 |
| 46 | PIK3CA | 1.24998645 |
| 47 | TTN | 1.22829015 |
| 48 | EPHA2 | 1.21278982 |
| 49 | FER | 1.19802329 |
| 50 | RIPK1 | 1.19420176 |
| 51 | PDPK1 | 1.16086310 |
| 52 | LATS2 | 1.13182469 |
| 53 | OXSR1 | 1.10835408 |
| 54 | CDK6 | 1.08774561 |
| 55 | TSSK6 | 1.05768577 |
| 56 | TYRO3 | 1.04815510 |
| 57 | PTK2B | 1.04291311 |
| 58 | FRK | 1.03046074 |
| 59 | PAK6 | 1.02427302 |
| 60 | MAP2K1 | 1.01606003 |
| 61 | WNK1 | 1.00796230 |
| 62 | EIF2AK3 | 1.00694681 |
| 63 | PRKAA2 | 1.00375855 |
| 64 | TAOK2 | 1.00364028 |
| 65 | MAP3K7 | 1.00342064 |
| 66 | CDK12 | 0.98256836 |
| 67 | YES1 | 0.97707280 |
| 68 | PKN2 | 0.96413737 |
| 69 | MELK | 0.94343934 |
| 70 | PRKD3 | 0.93984325 |
| 71 | BMX | 0.92902016 |
| 72 | TRPM7 | 0.92618570 |
| 73 | MAP3K9 | 0.92207234 |
| 74 | MAP3K3 | 0.91574607 |
| 75 | EIF2AK1 | 0.90312546 |
| 76 | JAK2 | 0.90206297 |
| 77 | PAK3 | 0.90203855 |
| 78 | STK3 | 0.89605422 |
| 79 | ABL2 | 0.89268922 |
| 80 | CAMK1G | 0.88357053 |
| 81 | SMG1 | 0.88142919 |
| 82 | ICK | 0.87507498 |
| 83 | PIM1 | 0.87457184 |
| 84 | SGK3 | 0.86331754 |
| 85 | MAP2K2 | 0.85940610 |
| 86 | ALK | 0.85414498 |
| 87 | MAP2K3 | 0.83960950 |
| 88 | STK38 | 0.82238001 |
| 89 | GSK3A | 0.81770920 |
| 90 | MAP3K6 | 0.79107322 |
| 91 | GRK1 | 0.79091779 |
| 92 | IRAK2 | 0.78835712 |
| 93 | TBK1 | 0.76033160 |
| 94 | MAPK11 | 0.75921815 |
| 95 | SGK494 | 0.75572598 |
| 96 | SGK223 | 0.75572598 |
| 97 | DYRK1B | 0.74406018 |
| 98 | MAP3K4 | 0.72866903 |
| 99 | FGR | 0.70890468 |
| 100 | PDGFRB | 0.70747002 |
| 101 | PKN1 | 0.70085908 |
| 102 | PDK1 | 0.69847657 |
| 103 | CAMK1D | 0.69729783 |
| 104 | MATK | 0.69687684 |
| 105 | MAP3K5 | 0.67228570 |
| 106 | NEK6 | 0.66636254 |
| 107 | EPHB2 | 0.66125030 |
| 108 | DAPK2 | 0.65635171 |
| 109 | EEF2K | 0.65322141 |
| 110 | NME2 | 0.63941391 |
| 111 | CSNK1G1 | 0.63721858 |
| 112 | WNK3 | 0.63072356 |
| 113 | TGFBR2 | 0.62687220 |
| 114 | CSK | 0.62654853 |
| 115 | NTRK1 | 0.62329364 |
| 116 | PDGFRA | 0.62212154 |
| 117 | MAP3K11 | 0.61408996 |
| 118 | PRKD1 | 0.61388825 |
| 119 | BLK | 0.60941548 |
| 120 | STK38L | 0.60619260 |
| 121 | PRKCZ | 0.60530344 |
| 122 | PRKCH | 0.59988671 |
| 123 | PDK2 | 0.59769833 |
| 124 | PRKAA1 | 0.57871823 |
| 125 | SGK2 | 0.57214570 |
| 126 | MAP3K13 | 0.56805858 |
| 127 | JAK1 | 0.56362084 |
| 128 | CDC42BPA | 0.55536506 |
| 129 | MTOR | 0.54677812 |
| 130 | SGK1 | 0.54262245 |
| 131 | ERBB2 | 0.54253002 |
| 132 | IRAK4 | 0.54112667 |
| 133 | CSNK1G2 | 0.53433274 |
| 134 | FGFR3 | 0.53342136 |
| 135 | KSR1 | 0.52316885 |
| 136 | IRAK1 | 0.52167689 |
| 137 | PRKCQ | 0.51562176 |
| 138 | PAK2 | 0.51213342 |
| 139 | MOS | 0.50461120 |
| 140 | MAP3K8 | 0.46710683 |
| 141 | BRSK1 | 0.45585529 |
| 142 | ARAF | 0.43488076 |
| 143 | JAK3 | 0.43013946 |
| 144 | GRK7 | 0.42142607 |
| 145 | PRKG2 | 0.41906043 |
| 146 | MST4 | 0.40105435 |
| 147 | MAPK7 | 0.38184384 |
| 148 | ERBB3 | 0.36101248 |
| 149 | RPS6KA2 | 0.35543361 |
| 150 | DYRK3 | 0.34680251 |
| 151 | TGFBR1 | 0.34664173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.60365237 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.62968604 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.19553402 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86975784 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.82707694 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45943996 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.37337046 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.21100939 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20525615 |
| 10 | Bile secretion_Homo sapiens_hsa04976 | 2.15141305 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.08013971 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06588201 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02179738 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97239126 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91997964 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.87788653 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85415647 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81811586 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72032790 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67199670 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60263050 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.56751093 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.53897247 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53765604 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53097349 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52312967 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49689127 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48838633 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.42142407 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42042895 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.41399576 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37134452 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36636927 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.34685990 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.32506360 |
| 36 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.32154419 |
| 37 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29724131 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28615616 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25498279 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.24285006 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23300186 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20266095 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19950719 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18524647 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14376110 |
| 46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.14267755 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 1.13263625 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.11210628 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09857298 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08021393 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08010342 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05741913 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05690301 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04682785 |
| 55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02771706 |
| 56 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.02399738 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98511265 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.98191593 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.97951756 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96512261 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96004551 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95803690 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 0.93925816 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.93925270 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.93335252 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91656212 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91590316 |
| 68 | Prostate cancer_Homo sapiens_hsa05215 | 0.91466347 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89094372 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88776094 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88350381 |
| 72 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.88174299 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87555682 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87350237 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.87175851 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.86037827 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84756015 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84157582 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80587446 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.80039219 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78629518 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77980335 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77882800 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77547376 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.77520345 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75786137 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74810625 |
| 88 | * Mineral absorption_Homo sapiens_hsa04978 | 0.74191638 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73673775 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73609123 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73449389 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72892896 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.69706181 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68099488 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67642797 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65881838 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65733410 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65681491 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64782338 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63554414 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.63348741 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62474933 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61190108 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60517158 |
| 105 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60297001 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60129702 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.59980600 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59119994 |
| 109 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58664243 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.58331404 |
| 111 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56078413 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56073309 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53170650 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.53066504 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52805584 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.52127905 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51735125 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50649493 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50379519 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49666085 |
| 121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49161200 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48554243 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46613538 |
| 124 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46497873 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45532171 |
| 126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44968143 |
| 127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42379654 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41919214 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38655101 |
| 130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36028678 |
| 131 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32470884 |
| 132 | Adherens junction_Homo sapiens_hsa04520 | 0.32098813 |
| 133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27332023 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24781511 |
| 135 | Salivary secretion_Homo sapiens_hsa04970 | 0.24695818 |
| 136 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23807957 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23213668 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22363069 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21549111 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20799053 |
| 141 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.20408115 |
| 142 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20398931 |
| 143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19896339 |
| 144 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.18845162 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17119709 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.16047920 |
| 147 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.15220977 |
| 148 | Tight junction_Homo sapiens_hsa04530 | 0.13830502 |
| 149 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.13817124 |
| 150 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.13404088 |
| 151 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13147603 |
| 152 | Bladder cancer_Homo sapiens_hsa05219 | 0.12901453 |
| 153 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.12835005 |
| 154 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09732825 |
| 155 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09635292 |
| 156 | Hepatitis C_Homo sapiens_hsa05160 | 0.09342640 |
| 157 | Metabolic pathways_Homo sapiens_hsa01100 | 0.09147571 |
| 158 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.08491215 |
| 159 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.08436666 |

